Skip to main content

Table 2 Unadjusted and adjusted (for baseline FVC and DLco) univariate analysis of overall survival in relation to baseline measures of collagen synthesis neoepitopes. Data shown for collagen-type 1 (P1NP), −type 3 (PRO-C3) and -type 6 (PRO-C6), the ratio of collagen synthesis: degradation ratios for collagen-type 1 (P1NP:C1M), −type 3 (PRO-C3: C3M), and –type 6 (PRO-C6: C6M) and lung function measurements (% predicted FVC and % predicted DLCO) in IPF subjects. The Hazard Ratio is based on a two-fold increase in the variable. Data are expressed as mean hazard ratio (HR) with 95% CIs for all thresholds and represent the associated change in mortality risk based on a 2-fold increase in the explanatory value

From: Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort

 

Univariate

Adjusted for LF

Group

Variable

Hazard Ratio (95% CI)

P value

Hazard Ratio (95% CI)

P value

 

P1NP

0.79 (0.60,1.05)

0.1013

0.81 (0.60,1.11)

0.1871

 

PRO-C3

1.49 (1.04,2.13)

0.0295

1.20 (0.74,1.93)

0.4577

 

PRO-C6

1.47 (0.84,2.59)

0.1787

1.11 (0.57,2.16)

0.7600

 

P1NP:C1M

0.67 (0.53,0.85)

0.0011

0.77 (0.60,0.99)

0.0389

 

PROC3:C3M

1.30 (0.91,1.85)

0.1542

1.17 (0.77,1.79)

0.4679

 

PROC6:C6M

0.87 (0.63,1.21)

0.4162

0.86 (0.59,1.26)

0.4319

 

% pred FVC

0.22 (0.12,0.39)

< 0.0001

  
 

% pred TLCO

0.16 (0.09,0.30)

< 0.0001